ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

ASCO Strategic Plan Seeks To Increase Value to Members, Public

May 24, 2002

In Brief: Clark, Hutchinson Gain New Honors; Nominations Open For Bristol-Myers Award; NIH Appointments

July 1, 1983

NCCS Networker Volume 1 Issue 1, March 1987

March 12, 1987

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Funding Opportunities.

April 19, 2002

NIH Plans Grants For Those Who Barely Miss Payline

April 19, 1991